Drug class
Tricyclic antidepressant; norepinephrine and serotonin reuptake inhibitor
Mechanism of action
Inhibits neuronal reuptake of noradrenaline and serotonin, increasing their availability in central synapses. It also interacts with muscarinic, histaminergic and adrenergic receptors typical of tricyclic antidepressants.
General use cases
- Treatment of depressive disorders in countries where melitracen is authorised.
- Used in fixed-dose combination with flupentixol in selected anxiety and depressive conditions where the combination is authorised.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
